Save
A SUCCESFUL CASE OF INTRADISCAL HYDROGEL IMPLANTATION FOR THE TREATMENT OF CHRONIC INTRACTABLE DISCOGENIC PAIN: A CASE REPORT
ESRA Academy. Koetsier E. Sep 8, 2016; 138281
Topic: PAIN THERAPY (ACUTE - CHRONIC)
Mrs. Eva Koetsier
Mrs. Eva Koetsier

Access to Premium content is currently a membership benefit.


Click here to join ESRA or renew your membership.

Abstract
Discussion Forum (0)
Rate & Comment (0)
Background and Aims:

Degenerative disc disease is one of the most common spinal pathologies. It is associated with disc dehydration, volume reduction, changes in cellular activity, biomechanical changes and painful symptoms. Analgesics and physical therapy often provide only temporary relief. There is controversy about the effectiveness of treatments like intradiscal injections (methylene blue), electrothermal therapy and biacuplasty. Furthermore, fusion or total disc arthroplasty are highly invasive surgeries with significant associated morbidity.

The hydrogel (GelStix™ Nucleus Augmentation Device) is composed of a hydrogel polymer, which expands in volume when implanted intradiscally. It acts as a reservoir of hydration, producing increased pressure, improved fluid exchange, and pH balance (figure 1).

We present a successful case of hydrogel implantation for the treatment of discogenic pain.

Methods:

A 44-year-old man presented with discogenic pain since one year, confirmed by MRI (figure 2). Before treatment he graded his pain as 8/10, despite being treated with physiotherapy and analgesics including 120 mg morphine daily. The hydrogels were inserted through the an 18 gauge needle in the nucleus pulposus (figure 3).

Results:

At 1 month follow-up, the patient reported reduction of pain to 2/10 and a reduction of morphine intake to 80 mg daily. He was able to walk better and was very satisfied with the treatment. At 3 months follow-up, the patient reported a pain score of 3/10, and the morphine consumption could be reduced to 35 mg daily.

Conclusions:

Hydrogel implantation can be a meaningful solution for the treatment gap existing between conservative care and invasive surgical intervention.



Reference: Kallewaard. Pain Pract. 2010;10:560-79.

Code of conduct/disclaimer available in General Terms & Conditions
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.


Save Settings